Trial Profile
Efficacy and Safety of GLP-1 first therapy compared with Insulin GLP-1 relay therapy in type 2 diabetes with inadequate glucose control: a randomized, open-label, multicenter parallel-group study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin degludec
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Dec 2021 Status changed from active, no longer recruiting to completed.
- 29 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 17 Jul 2014 New trial record